Mylan is a publicly traded company on the NASDAQ Global Select Market and incorporated under the laws of the Commonwealth of Pennsylvania, as set forth in its Articles of Incorporation.
The business and affairs of Mylan Inc. are managed under the oversight of the company's board of directors, which comprises 13 members. Each director is elected annually by the company’s shareholders. Certain of the directors’ duties, rights and responsibilities are detailed in the company’s Corporate Governance Principles as well as in the company’s Bylaws.
The board has established seven committees, each of which operates pursuant to a written charter (below).
The chief executive officer and other executive officers oversee management of the company’s business. Duties and standards of conduct for Mylan employees, officers and directors are set forth in the company’s Code of Business Conduct and Ethics, as well as in the Code of Ethics for the Chief Executive Officer, Chief Financial Officer and Corporate Controller.
Political Contribution & Trade Association Memberships Report
From time to time Mylan and MyPAC support political candidates and organizations of various parties, as well as ballot initiatives and trade associations which support public policies that contribute to pharmaceutical safety and innovation and further Mylan’s mission to provide 7 billion people with access to high quality medicine.
Mylan complies with the laws that govern lobbying efforts and political contributions. All of our employees must also comply with our Political Contributions and Activity Policy, which can be found above.
Our semiannual Mylan Inc. Political Contribution & Trade Association Memberships Report provides details of MyPAC which is funded by employee contributions; Mylan's political contributions (if applicable) to any political candidate, political organization, or ballot initiative; and the company's memberships in U.S. trade associations to which we contribute $50,000 a year or more and the portion (if applicable) devoted to lobbying activity.
Further, in accordance with the U.S. Lobbying Disclosure Act, Mylan files a quarterly report of expenses associated with lobbying the federal government. The report can be found on the U.S. Senate Office of Public Records website or the U.S. House of Representatives Office of the Clerk website.
July 1, 2013: Pursuant to Cal. Health and Safety Code §119400 et seq., Mylan Inc. including its subsidiaries, hereby certifies that it is in compliance with the provisions of Cal. Health and Safety Code §119402, including the requirement that it has adopted, and is in compliance with, a Comprehensive Compliance Program that it believes to be in accordance with the Office of Inspector General's Compliance Guidance for Pharmaceutical Manufacturers and the Code on Interactions with Health Care Professionals issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) on or about July 1, 2002 and as revised effective January 1, 2009.
To obtain a copy of Mylan’s Global Compliance Program and declaration, please call toll-free 866.252.4465 or make an electronic request.